New OTC dermatology products on the German market, including line extensions from Englehard, Medice and Stada and a 0.5% hydrocortisone cream from Sandoz.

Two prescription-to-OTC switch applications rejected by Germany’s Expert Committee for Prescription: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use.

Germany's Expert Committee for Prescription will meet on 22 January to consider two prescription-to-OTC switch applications: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use. 

In Vivo presents another installment of our quarterly reivew of dealmaking--in this case July-September 2003. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.